Companies: 10,795·Total market cap: $144.5T

CM Life Sciences III Inc.

CM Life Sciences III Inc.

CMLTNASDAQFinancial Services

$8.69

$-0.52(-5.65%)

Market Cap$4.2B

P/E Ratio—

52W High$9.17

52W Low$8.29

Avg Volume351K

Open$9.17

Beta0.00

Revenue Financials Earnings

CM Life Sciences III Inc. (CMLT) Revenue

Annual & quarterly revenue history · segment & region breakdown

CMLT · revenue · updated Jun 8, 2026

Core revenue metrics

Trailing 12 months

CM Life Sciences III Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

—

0 employees

FY

—

FY

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · CM Life Sciences III Inc. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

CMLT revenue by year · CMLT revenue history · CMLT annual revenue data

Compare revenue vs peers

Shell Companies

Compare CMLT revenue against listed peers. Click any row to open that company's revenue tab.

VG Acquisition Corp.

Gores Holdings VI, Inc.

GreenVision Acquisition Corp.

Forest Road Acquisition Corp.

Tuscan Holdings Corp.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CM Life Sciences III Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CM Life Sciences III Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CM Life Sciences III Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

CMLT revenue · 4 questions

CMLT's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CMLT revenueCMLT annual revenuewhat is CMLT revenueCMLT TTM revenue

▸ Source: FMP · CM Life Sciences III Inc. SEC filings · GAAP · CM Life Sciences III Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026